robert pickard
Jan 23, 2014
Can Novartis recover from a PR nightmare in Japan?
Allegations that Novartis violated Japanese law while promoting a blood-pressure drug have hurt the company in one of its largest markets. Experts say the damage could be long-lasting.
Top news, insights and analysis every weekday
Sign up for Campaign Bulletins